Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Pasithea Therapeutics (KTTA) Cash from Discontinued Operations (2022 - 2023)

Historic Cash from Discontinued Operations for Pasithea Therapeutics (KTTA) over the last 2 years, with Q4 2023 value amounting to -$16895.0.

  • Pasithea Therapeutics' Cash from Discontinued Operations rose 9780.49% to -$16895.0 in Q4 2023 from the same period last year, while for Dec 2023 it was -$611278.0, marking a year-over-year increase of 6597.57%. This contributed to the annual value of -$611278.0 for FY2023, which is 6597.57% up from last year.
  • Latest data reveals that Pasithea Therapeutics reported Cash from Discontinued Operations of -$16895.0 as of Q4 2023, which was up 9780.49% from -$11250.0 recorded in Q3 2023.
  • In the past 5 years, Pasithea Therapeutics' Cash from Discontinued Operations registered a high of $10698.0 during Q2 2022, and its lowest value of -$769680.0 during Q4 2022.